Omberacetam
| GVS-111 | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 318.40 g/mol [1] |
| Predicted LogP | 1.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H22N2O4 |
| IUPAC name | ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate |
| SMILES | CCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC2=CC=CC=C2 |
| InChI | InChI=1S/C17H22N2O4/c1-2-23-16(21)12-18-17(22)14-9-6-10-19(14)15(20)11-13-7-4-3-5-8-13/h3-5,7-8,14H,2,6,9-12H2,1H3,(H,18,22)/t14-/m0/s1 |
| InChIKey | PJNSMUBMSNAEEN-AWEZNQCLSA-N |
| CAS number | 157115-85-0 |
| UNII | 4QBJ98683M |
| PubChem CID | 180496 |
Omberacetam (N-Phenylacetyl-l-prolylglycine ethyl ester) (also known as Noopept, J759.455k, omberacetamum, (S)-Ethyl 2-(1-(2-phenylacetyl)pyrrolidine-2-carboxamido)acetate, n-phenylacetyl-l-prolylglycine ethyl ester, Glycine, 1-(phenylacetyl)-L-prolyl-, ethyl ester, N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester, ethyl (2-phenylacetyl)-L-prolylglycinate, ethyl 1-(phenylacetyl)-L-prolylglycinate or Glycine, 1-(2-phenylacetyl)-L-prolyl-, ethyl ester) is a substance of the carboxylic acid and phenethylamine class.
Chemistry
Stereochemistry []
Omberacetam is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Omberacetam matches Lipinski's rule of five.Reagents
There are currently 8 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | no color change | |
| Robadope | no pink color change | |
| Simon's | no blue color change | |
| Ehrlich | no color change | |
| Hofmann | no color change | |
| Morris | grey |
Pharmacology
MeSH Classification
- neuroprotective agents (M0028008)
Subjective effects []
| 0xea / Omberacetam [] | |
|---|---|
Routes:
| |
| a1ko / Omberacetam [] | |
|---|---|
Routes:
| |
| bonzi / Omberacetam [] | |
|---|---|
Routes:
| |
| magnus / Omberacetam [] | |
|---|---|
Routes:
| |
Experience reports
Erowid
There are currently 13 experience reports involving omberacetam on Erowid: []- "A Potentiation/Synergy Analysis" by NyxAether
- "I Felt My Brain Was Working Better" by DowntownBound
- "The Writing Drug" by ThePoobaman
- "Excellent LSD Substitute" by Themadpsyentist
- "Clean Clear Subtle" by ThePoobaman
- "Unexpectedly Life-Changing" by FireFly-INC.
- "Unexpected Potentiation" by MrGecko
- "Did Not Make Me Smarter" by TryptamineLover
- "Ego Death and Rebirth" by SerotoninVampire
- "Enlightenment" by Phox
- "The Wonders of Nootropics" by Mr_Nice_Guy
- "Weird Bad Risky" by Thewatchfuleye
- "Self-Analysis With Assistance" by Lucid Cipher
- "There are 45 psychedelic and dissociative trip reports in the Drug Users Bible: Download a free copy from here. Whether psychedelics are used for recreation, you need to look after yourself. Stay safe." by DMTrott (3 upvotes)
- "500ug of lad research chemicals. 24 filled with Enjoyable and absolutely insane philosophical ideas." by vasily111 (1 upvotes)
- "9/22/2021 pyra (xan like) and mph (methylphenidate like)" by WhatAHenk (0 upvotes)
Legal status []
- Australia: Omberacetam is a Schedule 4.
- United States: Omberacetam is a Unapproved "New Drug" (as defined by 21 U.S. Code ยง 321(p)(1)). Use in dietary supplements, food, or medicine is unlawful; otherwise uncontrolled.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 180496, Omberacetam. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/180496
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Omberacetam. UNII: 4QBJ98683M. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4QBJ98683M
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:01:24 |
| drugspro | ok | 2026-11-20 08:01:20 |
| erowid | ok | 2026-11-20 08:01:22 |
| gsrs | ok | 2026-11-20 08:01:21 |
| hmdb | missing (no HMDB id) | 2026-11-20 08:01:20 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 08:01:26 |
| pubchem | ok | 2026-11-20 08:01:20 |
| ok | 2026-11-20 08:01:20 | |
| sider | missing (not in SIDER) | 2026-11-20 08:01:20 |
| structure | ok | 2026-11-20 08:01:20 |
| wikipedia | ok | 2026-11-20 08:01:21 |